China Pharma Holdings
CPHI
7 hedge funds and large institutions have $240K invested in China Pharma Holdings in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
9% more capital invested
Capital invested by funds: $220K → $240K (+$20K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$39.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.6K |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
+$740 |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18.1K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$3K |
| 3 |
VF
Virtu Financial
New York
|
-$1.85K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $212K | +$39.9K | +324 | +22% |
|
|
2
UBS Group
Zurich,
Switzerland
| $10K | +$9K | +73 | +811% |
|
|
VF
3
Virtu Financial
New York
| $8K | -$1.85K | -15 | -17% |
|
|
4
Citadel Advisors
Miami,
Florida
| $6K | -$18.1K | -147 | -74% |
|
|
PCM
5
Parsons Capital Management
Providence,
Rhode Island
| $2K | – | – | – |
|
|
NFG
6
Next Financial Group
Houston,
Texas
| $1K | +$740 | +6 | New |
|
|
7
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | +$1.6K | +13 | New |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$3K | -21 | Closed |
|
CPHI Hedge Fund Activity: Q4 2019 in Review
7 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q4 2019, worth a combined $240K — up 9.1% from $220K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CPHI positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $39.9K. The largest seller was Citadel Advisors, cutting an estimated $18.1K.
- 7 institutional investors held China Pharma Holdings (CPHI) as of Q4 2019, up from 6 in Q3 2019.
- Funds reported $240K of China Pharma Holdings stock for Q4 2019, up 9.1% quarter-over-quarter.
- 2 funds opened new China Pharma Holdings positions in Q4 2019 and 1 closed out, a net change of +1 holder.
- The largest China Pharma Holdings buyer in Q4 2019 was Renaissance Technologies, an estimated $39.9K added.
- The largest China Pharma Holdings seller in Q4 2019 was Citadel Advisors, an estimated $18.1K sold.
Based on aggregated 13F filings for Q4 2019.